Pubblicazioni Scientifiche

Dermatologia

10 apr 2018

An open-label exploratory study evaluating the efficacy and safety of ingenol mebutate gel 0.05% for the treatment of verruca vulgaris navigation-next-alternate

A recent case study series provided evidence for the efficacy of ingenol mebutate against anogenital warts

10 apr 2018

Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum. A Delphi Consensus of International Experts navigation-next-alternate

A Delphi Consensus of International Experts

06 apr 2018

Gender differences in genital lichen sclerosus navigation-next-alternate

Studies specifically conducted to assess gender differences in genital lichen sclerosus (GLS) are not available. This multicenter study aimed to identify possible gender-related differences on GLS clinical features, history and course, through collecting data from a large mixed-sex sample of patients

06 apr 2018

Dermoscopic Features of Basal Cell Carcinoma on the Lower Limbs: A Chameleon! navigation-next-alternate

Lower limbs represent an uncommon location for basal cell carcinoma (BCC) and only few reports have described dermoscopic features of BCC in this body site. Since BCCs of the lower limbs frequently display nonclassic BCC dermoscopic criteria, they can simulate other benign or malignant lesions

06 apr 2018

Dermoscopy features of atypical fibroxanthoma: A multicenter study of the International Dermoscopy Society navigation-next-alternate

This was a case-control study. Atypical fibroxanthoma lesions were compared with a control group with non-melanoma skin cancer

06 apr 2018

Childhood trauma and resilience in psoriatic patients: A preliminary report navigation-next-alternate

The aim of the study was to investigate childhood trauma and resilience in a psoriatic sample compared with healthy controls. Correlations between childhood trauma, resilience, quality of life, clinical data and psoriatic features were also evaluated

02 apr 2018

Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the BADBIR navigation-next-alternate

Serious infection is a concern for patients with psoriasis receiving biologic therapies. We assessed the risk of serious infections for biologics used to treat psoriasis by comparison with a cohort receiving non-biologic systemic therapies in a propensity score-weighted Cox proportional hazards model using data from the BADBIR

02 apr 2018

Wide skin markings pattern: melanoma descriptor or patient-related factor? reply from the authors navigation-next-alternate

We read with great interest the letter by Rishpon and Colleagues on our paper titled "Uncovering the diagnostic dermoscopic features of flat melanomas located on the lower limbs"

02 apr 2018

Chronic urticaria and the metabolic syndrome: a cross-sectional community-based study of 11 261 patients navigation-next-alternate

Objective: evaluate the association between CU and metabolic syndrome and its components in a large community?based medical database

20 gen 2018

Association of Psoriasis With Comorbidity Development in Children With Psoriasis navigation-next-alternate

Objective: determine the risk of elevated lipid levels (hyperlipidemia/hypertriglyceridemia), hypertension, metabolic syndrome, polycystic ovarian syndrome, diabetes, nonalcoholic liver disease, and elevated liver enzyme levels in children with and without psoriasis, after accounting for obesity

20 gen 2018

Do perioperative antibiotics reduce the risk of surgical-site infections following excision of ulcerated skin cancers? A Critically Appraised Topic navigation-next-alternate

Aim: review the efficacy of perioperative antibiotics in reducing the risk of surgical-site infections (SSIs) following excision of ulcerated skin cancers

20 gen 2018

Epidemiology of atopic dermatitis in adults: results from an international survey navigation-next-alternate

Prevalence of adult AD ranged from 2.1% to 4.9% across countries. Severe AD represented a small proportion of the overall AD population regardless of measure or region.

15 gen 2018

Alopecia areata: an appraisal of new treatment approaches and overview of current therapies

The second article in this continuing medical education series describes the evidence supporting new treatment methods, among them Janus kinase inhibitors

15 gen 2018

Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors navigation-next-alternate

While the majority of cutaneous squamous cell carcinomas (cSCCs) can be treated surgically, the additional work-up and treatments indicated for high-risk cSCC remain undefined

15 gen 2018

Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging navigation-next-alternate

Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous epithelium, represents 20% to 50% of skin cancers

15 gen 2018

Diagnosis and management of moderate to severe adult atopic dermatitis navigation-next-alternate

A consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA)

09 gen 2018

Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta-analysis of randomized controlled trials

Objective: determine the impact of dupilumab on rates of skin and other infections in patients with moderate-to-severe AD

09 gen 2018

Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis

Part one of this two-part continuing medical education series describes the epidemiology, clinical evaluation, prognosis, and recent advancements in the understanding of the pathogenesis of AA

29 nov 2007

Cellule dendritiche plasmocitoidi attivate da DNA autologo associato ad un peptide antimicrobico

In seguito all'identificazione del peptide antimicrobico LL37 responsabile dell'attivazione delle cellule plasmacitoidi, la psoriasi può essere finalmente definita come una malattia autoimmunitaria

08 nov 2007

L'immunità innata nella psoriasi

Nuovi concetti patogenetici nella psoriasi, dall'immunità adattativa ai nuovi target terapeutici dell'immunità innata